Levity in plain terms: brand-name GLP-1s, billed in two parts
Levity runs a cash-pay weight loss program built on brand-name GLP-1 injections, the incretin-based medicines known generically as semaglutide and tirzepatide. You pay a recurring care fee for the clinical side, then pay for the drug itself, and the drug is the number that decides your budget. On the advertised one-month self-pay basis the entry point is $179 a month, with the caveat that travels with it: program rate; brand-name GLP-1 medication $1,199 to $1,599/mo. That combination suits someone who wants FDA-approved product with an approved label and a documented dose ladder, and who can absorb a four-figure monthly bill with no insurance help. Anyone who turned to telehealth mainly to make a GLP-1 cheaper will find lower-cost routes in this category.
The points in its favor are verifiable rather than promotional: LegitScript certification, and brand-name only dispensing that keeps the program clear of the compounded and counterfeit supply problems the FDA has documented. The trade-offs are just as plain. One drug class, injectables only, no insurance billing, and a total monthly outlay near the top of the market.
The money: one care fee, one pharmacy bill, no bundling
Two charges, billed separately. The care fee is $179 a month (program rate; brand-name GLP-1 medication $1,199 to $1,599/mo), and the medicine is invoiced per fill at brand pharmacy rates rather than folded into the membership. Read any headline figure in this category with that split in mind, because a low monthly number almost always buys the clinical service and not the pen.
What the care fee actually buys
The recurring fee covers the clinical relationship: your intake evaluation, the decision to write a prescription, dose changes as you climb the ladder, and follow-up messaging with the care team. It does not buy the drug. Ask whether baseline bloodwork, shipping and any nutrition coaching sit inside that fee or bill on their own, since those three items are where cash-pay weight programs differ most.
What the medication adds each month
Brand-name semaglutide is quoted at $1,199 for a one-month supply and brand-name tirzepatide at $1,299, with the published range topping out at $1,599. These behave like retail drug charges, not membership charges. Manufacturer savings cards, if you qualify for one, apply to the medicine rather than to the care fee, so ask whether the program will process one for you.
Month one, month six, and what moves
Billing runs month to month, and the care side is a flat recurring rate rather than a teaser that jumps at renewal. The variable is the pharmacy line. Maintenance doses sit well above starting doses, so ask in writing whether your quoted drug figure holds across the whole ladder or changes when you step up. Get that answer before the second fill, not after it.
What the quoted numbers leave out
- Baseline and follow-up labs, if your clinician orders them
- Any in-person care, imaging or specialist referral
- Sharps disposal and replacement supplies if a pen arrives damaged
- Anything your own health plan might have paid, since this route bills you directly
Judge this program annually, at maintenance dose, care fee included. Our sample savings report shows the format we use to line up cash-pay totals across routes.
What a year actually costs
Programmes quote a monthly headline. Add the medication, the labs and the renewal price and the real number is usually different.
Advertised prices change often and intro pricing rarely lasts. Ask what the renewal rate is before you commit to a plan.
The semaglutide track: weekly injection, five-step ladder
How semaglutide works
Semaglutide is a GLP-1 receptor agonist, a medicine that copies a gut hormone released after eating. It slows how fast the stomach empties and acts on appetite signaling in the brain, so most people eat less without fighting themselves at every meal. Plain patient guidance on the injection is set out by MedlinePlus drug information.
The dose ladder the label sets
Approved labeling for chronic weight management starts at 0.25 mg once weekly for four weeks, then steps through 0.5 mg, 1 mg and 1.7 mg to a 2.4 mg maintenance dose, holding at least four weeks per step (FDA prescribing information). The slow climb is the point: it is how nausea is kept survivable. Any program willing to rush it is not doing you a favor.
What the trial evidence shows
In the 68-week STEP 1 trial, adults on semaglutide 2.4 mg with lifestyle support lost about 14.9% of body weight on average, against 2.4% on placebo (peer-reviewed trial report). Individual results scatter widely around that average, and weight commonly returns when the medicine stops. That matters here, because stopping is often a budget decision at these prices.
Side effects and the warnings that matter
Nausea, vomiting, diarrhea, constipation and stomach pain are the usual complaints, and they peak in the days after each increase. Labeling also flags pancreatitis, gallbladder disease, kidney injury from dehydration, and low blood sugar when the drug is combined with insulin or a sulfonylurea. The label carries a boxed warning about thyroid C-cell tumors seen in rodents, and it should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2 (FDA label, boxed warning). Tell your clinician about any planned surgery under anesthesia, since delayed stomach emptying changes fasting instructions.
What this track costs inside the program
$1,199 for a one-month supply of brand-name product, charged on top of the care fee and on a separate line. Compare that against a compounded semaglutide program and the gap is large; compare it against a covered brand prescription through an employer plan and it may be larger still, in the other direction. Our semaglutide dosing and side effects guide covers the molecule itself in more depth.
Who this track suits
People who want the approved product and a label they can read, who have no thyroid cancer history, who are not pregnant or trying to conceive, and who can pay cash without wrecking the rest of the budget. People who already failed semaglutide on tolerance grounds should discuss the second track instead.
The tirzepatide track: dual-hormone action, higher list price
How tirzepatide differs
Tirzepatide acts on two gut hormone receptors, GIP and GLP-1, rather than one. In practice patients describe similar appetite suppression with a slightly different side-effect feel, and the trial numbers run higher. MedlinePlus tirzepatide information covers the basics in patient language.
The dose ladder
Approved labeling for weight management begins at 2.5 mg once weekly for four weeks, then moves to 5 mg, with further increases of 2.5 mg after at least four weeks at the current dose, to maintenance at 5 mg, 10 mg or 15 mg (FDA prescribing information). More steps means more check-ins, which is exactly what the care fee should be paying for.
What the trial evidence shows
In SURMOUNT-1, adults without diabetes lost roughly 15% to 21% of body weight over 72 weeks depending on dose, alongside lifestyle changes (peer-reviewed trial report). As with semaglutide, averages hide a wide spread of individual outcomes.
Side effects, plus one warning people miss
Gastrointestinal effects dominate again, with the same class-level cautions on pancreatitis, gallbladder problems, dehydration and hypoglycemia in combination with certain diabetes drugs. The boxed warning on thyroid C-cell tumors and the MEN 2 contraindication apply here too. One detail that catches people out: tirzepatide labeling warns that oral hormonal contraceptives may become less effective, and advises a non-oral method or an added barrier method for four weeks after starting and after each dose increase. Raise this at intake rather than after the first pen.
What this track costs inside the program
$1,299 for a one-month supply of brand-name product, again separate from the care fee. The higher list price does not buy extra clinical service; it is the drug. Read how tirzepatide is dosed before you commit to a maintenance target, because the number of steps affects how long you stay at a lower cost tier and how many check-ins you need.
Who this track suits
Patients who want the strongest trial evidence in the class, who can tolerate a longer titration, and who understand that a switch mid-program means restarting the ladder near the bottom.
How the two tracks compare on care, not price
| Track | What it targets | Mechanism | Dose steps and cadence | Monitoring worth scheduling |
|---|---|---|---|---|
| Brand-name semaglutide | Chronic weight management in adults meeting label criteria | Single GLP-1 receptor agonist | Five doses, at least four weeks per step | Gut tolerance, hydration, gallbladder symptoms, thyroid history at intake |
| Brand-name tirzepatide | Chronic weight management in adults meeting label criteria | Dual GIP and GLP-1 receptor agonist | Up to six doses, 2.5 mg increments after four weeks | All of the above, plus contraception method if using oral hormonal birth control |
Both are weekly self-injections that need refrigeration, so shipping reliability is a clinical issue and not a logistics footnote.
Semaglutide vs. Tirzepatide Track
| Semaglutide | Tirzepatide | |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GIP + GLP-1 agonist |
| Starting dose | 0.25 mg weekly | 2.5 mg weekly |
| Dose steps | 5 steps | Up to 6 steps |
| Trial weight loss (avg) | ~14.9% over 68 weeks | ~15-21% over 72 weeks |
| Monthly drug cost | $1,199 | $1,299-$1,599 |
| Extra contraception warning | No | Yes - oral hormones may be less effective |
Who prescribes, who qualifies, and how titration is handled
Care runs through licensed clinicians who evaluate you remotely and write the order if the medicine is appropriate. Telehealth does not remove that step: a legitimate GLP-1 program always puts a clinician between you and the pharmacy, and this one is built that way. Ask which state your assigned clinician is licensed in, whether your intake is a live video visit or an asynchronous questionnaire reviewed by a clinician, and whether you can message the same person about a side effect at week three.
Label criteria for these medicines cover adults with a BMI of 30 or above, or 27 or above with a weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. Check where you sit before you start an intake, since that single number shapes the whole conversation.
BMI calculator
Most weight-loss programmes screen on BMI before they will prescribe. This is the number they will use.
A screening number, not a diagnosis. It does not distinguish muscle from fat, and it reads high for muscular builds.
Labs are the piece to pin down. Brand-name GLP-1 care does not always require bloodwork, but a thoughtful program will want a baseline for kidney function, blood sugar and, where relevant, thyroid and liver markers, then a recheck once you reach maintenance. Ask whether labs are ordered, who pays for them and where you draw them. Our scoring approach for providers explains why titration cadence and monitoring carry as much weight as headline price.
Signing up: what the sequence looks like
Step 1: Intake and health history
You complete a medical questionnaire covering weight history, current medicines, personal and family thyroid cancer history, pancreatitis, gallbladder disease, pregnancy plans and diabetes status. Answer the thyroid and pregnancy questions precisely; they are the ones that stop a prescription.
Step 2: Clinician review and the prescribing decision
A licensed clinician reviews your file and decides whether a GLP-1 is appropriate and which molecule to start. Approval is never guaranteed, and a declined intake is a sign the screen worked.
Step 3: Confirming what you will pay
Before you authorize anything, get the care fee and the medication figure on the same screen or in the same email. These are separate charges on separate schedules, and the pharmacy line is the one that moves.
Step 4: Pharmacy fulfilment and delivery
Brand-name pens ship cold and need refrigeration on arrival. Confirm the shipping window, what happens if a package sits on a doorstep in summer heat, and who replaces a spoiled shipment.
Step 5: Titration check-ins
Expect a check-in around each four-week step, either by message or a short visit. If you are struggling with nausea, that check-in is where you ask to hold a dose rather than climb.
Step 6: Refills and continuity
Refills should be timed so you never skip a weekly dose during a step up. Ask how far in advance the next fill is triggered and what happens if a payment fails.
State coverage is worth settling at step one. Remote prescribing requires a clinician licensed where you are physically located, so confirm your state is served before you pay anything. The telehealth provider directory is a reasonable place to see how coverage varies across the category.
Support and refills: the questions that decide the experience
After the first shipment, support quality becomes the whole product. The care fee is buying access to people, so test that access early. Send a low-stakes message in week one and time the reply. That single data point tells you more than any marketing page about what week ten will feel like.
Three things to establish up front: which channels exist and their hours, who answers a side-effect question outside those hours, and how a delayed or damaged shipment is handled mid-titration. Missed doses are a real risk in cold-chain programs. Semaglutide labeling advises that if a weekly dose is missed and the next scheduled dose is more than two days away, take it as soon as possible; if it is closer than that, skip it and resume the normal schedule. Confirm that guidance with your own clinician rather than improvising.
Quick tip: Save the care team message thread and any dose instructions to your own device, so a switch later does not cost you your history.
Cancelling, refunds and pausing between doses
Month-to-month billing is the useful part: no long contract is required to start. The details that decide whether that flexibility is real are the notice period, the cut-off date relative to your billing anniversary, and whether cancelling the care fee also stops any pending pharmacy charge.
Dispensed medicine is generally not returnable once it leaves a pharmacy, which is standard across the industry rather than a quirk of this program. So the practical rule is simple: cancel before the next fill is triggered, not after the box ships. Ask for the refund window in writing, ask whether pausing is possible if you need a month off, and keep the confirmation email.
Privacy and data practices worth checking before you upload an ID
Clinical records created by a licensed clinician sit under HIPAA. Marketing analytics on a consumer website often do not, and that gap is where weight-loss telehealth has drawn scrutiny generally. Read the privacy policy for four specific things: what health data is collected at intake, whether any of it is shared with advertising or analytics partners, how long records are retained, and how you request deletion of your account data.
Two practical habits reduce your exposure. Decline optional marketing consent at signup if you do not want your data used for ad targeting, and ask for a copy of your clinical record before you cancel, since retrieving it later is slower.
Trust and safety record: certification, sourcing and the compounding question
LegitScript certification is in place for this provider, which is the single most useful third-party signal in this category and one a lot of GLP-1 sellers cannot show. Certification checks licensing, sourcing and advertising practices; you can confirm any operator through the LegitScript certification lookup. It does not vouch for pricing, service speed or clinical outcomes, so treat it as a floor rather than a recommendation.
The sourcing choice carries real weight. Because this program dispenses brand-name product rather than compounded copies, it sits outside the lane where the FDA has repeatedly raised alarms, including dosing errors with compounded GLP-1s and salt forms that are not the approved active ingredient (FDA safety communication). The agency has also warned consumers about counterfeit Ozempic found in the legitimate US supply chain (FDA counterfeit alert), which is a reason to check pen packaging and lot numbers on arrival whoever you buy from.
On transparency, both charges are published before intake rather than revealed after a questionnaire, and that is a genuine mark in its favor when so much of this market hides the number until you have handed over your medical history. The gaps to close yourself are the refund window, the cancellation notice period and the lab policy, all of which deserve a direct answer before payment.
Insurance, coverage and why this stays a cash decision
This program does not bill insurance. Everything you pay is self-pay, which is a fair model to run but an expensive one to choose blindly. Before committing, spend an hour on your own coverage. Some employer plans cover brand-name weight-management drugs with prior authorization, and where they do, your copay can land far below the four-figure cash figure quoted here.
Medicare works differently. Part D plans have historically been restricted from covering drugs used for weight loss alone, though coverage can apply when the same molecule is prescribed for another approved condition; the current rules are set out on Medicare.gov drug coverage. If you are on Medicare, get your plan’s answer in writing before you start paying cash.
Cash pay still wins for some people: no prior authorization fight, no step therapy, no denial letters. Just be sure you are choosing it rather than defaulting to it. The weight loss medication index is a starting point for comparing what the same molecules cost through different routes.
Where Levity makes sense, and where it does not
Anyone reading a Levity review is usually deciding between approved product at full price and a compounded version at a fraction of it. That is the real fork here. This program makes sense if you want the FDA-approved pen with its label, its dose ladder and its known supply chain, if you have already checked and confirmed your plan will not cover it, and if a four-figure monthly total is genuinely affordable for a year rather than a quarter.
Look elsewhere if cost is the binding constraint, if you want an oral or non-GLP-1 option, if you need a program that will fight an insurance denial on your behalf, or if you want bundled labs and coaching inside a single monthly figure. Patients in those situations should read across the category first; the current GLP-1 telehealth comparison shows how the cash-pay and brand-name models line up against each other.
Questions to ask before you pay, and what to ask your current provider
Ask Before You Pay
- Does the quoted drug price hold at maintenance dose or rise with each step up?
- Are baseline and follow-up labs included in the care fee or billed separately?
- Is intake a live video visit or an asynchronous questionnaire?
- Which state is my assigned clinician licensed in?
- What is the cancellation cut-off relative to my billing date?
- Who handles a side-effect message on a weekend, and how fast?
- Will the program process a manufacturer savings card on the medication?
- Does the medication figure quoted at intake hold at maintenance dose, or change with each step?
- Are baseline and follow-up labs included, ordered separately, or left to me?
- Is my intake a video visit or an asynchronous review, and which state is my clinician licensed in?
- What is the cancellation cut-off relative to my billing date, and what is refundable after a shipment leaves?
- Who responds to a side-effect message on a weekend, and how fast?
If you are switching from another program, ask that one for three things before you cancel: a copy of your clinical records including dose history, confirmation of your final billing date, and the timing of your last shipment so you do not create a gap in weekly dosing. Then put both totals side by side. Our Run My Numbers calculators help you get the twelve-month comparison right rather than comparing a first-month promotion against a maintenance bill.
Reputation check: reading past the band
Searching this brand is genuinely difficult, because an electronic music trio of the same name owns the general results with tour dates, streaming profiles and ticket listings. A Levity review that leaned on those pages would be reviewing a band, not a clinic. Patient sentiment has to be gathered from named, attributable sources instead.
Three places are worth your time: the company’s Better Business Bureau profile, the Apple App Store listing and the Google Play listing. Read recent entries rather than the headline average in each case, since both app scores and complaint volumes shift month to month, and a single bad release can drag a rating that has nothing to do with clinical care. Weight the complaints that describe process failures over the ones that describe disappointment with results.
In this category, the complaint themes that predict real trouble are consistent: billing that continues after a cancellation request, shipments that slip during a dose increase, and clinicians who go quiet when side effects worsen. Ask about all three before you pay, then judge the answers against what recent reviewers describe. On the verifiable record, LegitScript certification is in place and the program dispenses approved brand-name product, which keeps it clear of the compounded and counterfeit problems that dominate FDA enforcement in this space. Community reviews on our own pages are moderated, and any incentivized review is labeled as such.
Educational content, not medical advice. Always consult a qualified clinician before starting, stopping or switching treatment.